Skip to main content
PuraPharm Corporation Limited logo

PuraPharm Corporation Limited — Investor Relations & Filings

Ticker · 1498 ISIN · KYG7306Y1044 HKEX Manufacturing
Open in API
Filings indexed 426 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1498

About PuraPharm Corporation Limited

http://www.purapharm.com

PuraPharm Corporation Limited specializes in the research, development, production, marketing, and sale of modernized Chinese medicine products. The company's core offering is Concentrated Chinese Medicine Granules (CCMG), primarily marketed under the Nong’s® brand for professional use. PuraPharm is the largest supplier of CCMG in Hong Kong, holding a leading market share. It is the only non-PRC company licensed by the China NMPA to manufacture and sell CCMG products in China, and the only Chinese medicine manufacturer whose CCMG products are verified and recognized by the United States Pharmacopeia. PuraPharm provides a total solution in Chinese medicine, which includes an extensive range of CCMG products, Chinese healthcare products for retail, and a proprietary patented automated clinic and hospital management and dispensing system. The company utilizes world-class R&D and internationally GMP-certified manufacturing facilities.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-07 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Regulatory Filings Classification · 95% confidence The document is an announcement regarding proposed amendments to the Articles of Association of PuraPharm Corporation Limited. It mentions seeking shareholder approval at the forthcoming AGM and details the nature of the amendments to the company's governance documents. The document is relatively short (2984 characters) and serves as a notification of proposed changes rather than the actual amended articles or a detailed governance report. It is not a full governance report (CGR) or a management report but an announcement related to governance changes. Given the nature and length, it fits best as a Regulatory Filing (RNS) because it is a formal announcement under listing rules about proposed governance amendments, not the actual report or meeting materials themselves.
2026-04-30 English
PROXY FORM FOR ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a proxy form for the Annual General Meeting (AGM) of PuraPharm Corporation Limited. It includes instructions for shareholders to appoint proxies to vote on their behalf at the AGM, details of resolutions to be voted on, and procedural notes related to the meeting. The content is focused on the meeting logistics and voting process rather than the presentation or materials shared during the AGM itself. This type of document is classified as AGM Information (AGM-R) because it is directly related to the AGM and is a standard form used for shareholder participation in the meeting.
2026-04-30 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of an Annual General Meeting (AGM) for PuraPharm Corporation Limited. It includes details about the meeting date, location, agenda items such as re-election of directors, adoption of financial statements, appointment of auditors, and approval of mandates related to share buybacks and issuance. The document does not contain the actual financial statements or detailed financial data but rather serves as a formal notice to shareholders about the AGM and the resolutions to be considered. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or notices about it. The document length is over 13,000 characters, indicating it is a full notice rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2026-04-30 English
(I) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (II) PROPOSED GRANT OF GENERAL MANDATES TO BUY BACK SHARES AND ISSUE NEW SHARES; (III) AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND PROP
AGM Information Classification · 95% confidence The document is a circular from PuraPharm Corporation Limited dated 4 May 2026, addressing shareholders about the upcoming Annual General Meeting (AGM) scheduled for 27 May 2026. It includes detailed information on the proposed re-election of retiring directors, proposed general mandates to buy back and issue shares, amendments to the memorandum and articles of association, and the notice of the AGM itself. The document contains extensive content including definitions, letters from the board, appendices with director details, explanatory statements on share buy-back mandates, and the full notice of the AGM. This is characteristic of a circular or proxy statement related to an AGM rather than a simple announcement or a full annual report. The document is not a financial report or earnings release, nor is it a regulatory filing or a report publication announcement. It is a comprehensive shareholder circular containing AGM materials and proxy information. According to the filing definitions, presentations and materials shared during the Annual General Meeting fall under AGM Information (AGM-R). Given the detailed nature and the focus on AGM matters, the appropriate classification is AGM Information (AGM-R).
2026-04-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 85% confidence The document consists solely of a list of the company’s board members (executive, non-executive, independent non-executive) and their committee roles. There is no discussion of financial results, legal matters, dividends, or investor guidance; rather it is an announcement of board composition and functions. According to our taxonomy, this aligns with Board/Management Information (MANG), which covers announcements of the company’s board of directors or senior management positions.
2026-04-27 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.